AVALGLUCOSIDASE ALFA-NGPT

AVALGLUCOSIDASE ALFA-NGPT was reported 998 times

AVALGLUCOSIDASE ALFA-NGPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY HEXOSE TETRASACCHARIDE INCREASED 16 0.4103
1 COMPLEMENT FACTOR C3 2 0.2857
2 TONSILLAR ATROPHY 1 0.1667
3 GLYCOGEN STORAGE DISEASE TYPE II 11 0.1048
4 ELECTROCARDIOGRAM PACEMAKER SPIKE 1 0.0833
5 COMPLEMENT FACTOR C3 INCREASED 7 0.0667
6 CAPRIPOX VIRAL INFECTION 1 0.0588
7 LYSOSOMAL STORAGE DISORDER 1 0.0526
8 RASH NEONATAL 1 0.0303
9 MACULAR TELANGIECTASIA 1 0.0303
10 DRUG SPECIFIC ANTIBODY PRESENT 150 0.0230
11 CATHETER SITE SCAR 1 0.0167
12 IMMUNE TOLERANCE INDUCTION 1 0.0147
13 LUNG ADENOCARCINOMA STAGE I 1 0.0139
14 NEUTRALISING ANTIBODIES POSITIVE 5 0.0120
15 TETHERED ORAL TISSUE 1 0.0119
16 ANTIBODY TEST NEGATIVE 2 0.0102
17 EYELID MYOCLONUS 1 0.0100
18 RESPIRATORY MUSCLE WEAKNESS 3 0.0093
19 INCISION SITE OEDEMA 1 0.0072
20 OCULAR STROKE 1 0.0072
21 INCLUSION BODY MYOSITIS 1 0.0067
22 INFUSION RELATED HYPERSENSITIVITY REACTION 4 0.0067
23 DIAPHRAGM MUSCLE WEAKNESS 1 0.0063
24 EUSTACHIAN TUBE OBSTRUCTION 1 0.0061
25 TRYPTASE INCREASED 4 0.0056
26 PANCREATIC DUCT OBSTRUCTION 1 0.0056
27 INFLUENZA B VIRUS TEST POSITIVE 1 0.0055
28 GLOBOTRIAOSYLSPHINGOSINE INCREASED 1 0.0051
29 NONREASSURING FOETAL HEART RATE PATTERN 1 0.0045
30 PLACENTAL INFARCTION 1 0.0045
31 PULMONARY CONTUSION 1 0.0040
32 INCISION SITE DISCHARGE 1 0.0040
33 COOMBS TEST POSITIVE 1 0.0037
34 MACROGLOSSIA 2 0.0036
35 MOTOR DEVELOPMENTAL DELAY 2 0.0035
36 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
37 TISSUE INFILTRATION 1 0.0034
38 INFUSION SITE URTICARIA 2 0.0030
39 ADMINISTRATION SITE BRUISE 1 0.0029
40 CIRCUMORAL OEDEMA 1 0.0029
41 LORDOSIS 1 0.0028
42 MECONIUM IN AMNIOTIC FLUID 1 0.0028
43 FOETAL EXPOSURE TIMING UNSPECIFIED 2 0.0028
44 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
45 INFUSION SITE IRRITATION 3 0.0023
46 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
47 INCISIONAL DRAINAGE 1 0.0023
48 INFUSION SITE SCAR 1 0.0023
49 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
50 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
51 INFUSION SITE EXTRAVASATION 13 0.0021
52 PLAGIOCEPHALY 1 0.0020
53 ORTHOPAEDIC PROCEDURE 1 0.0019
54 MOLLUSCUM CONTAGIOSUM 1 0.0019
55 DOSE CALCULATION ERROR 1 0.0017
56 INCISION SITE PAIN 2 0.0017
57 UMBILICAL CORD AROUND NECK 1 0.0017
58 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
59 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
60 NEURODEGENERATIVE DISORDER 1 0.0016
61 GLUCOSE URINE PRESENT 2 0.0016
62 BLADDER IRRITATION 1 0.0016
63 FORCED VITAL CAPACITY DECREASED 1 0.0015
64 POSTPARTUM HAEMORRHAGE 2 0.0015
65 ABSCESS NECK 1 0.0015
66 CARBON DIOXIDE INCREASED 2 0.0015
67 INFUSION SITE INFLAMMATION 1 0.0014
68 DERMATITIS DIAPER 1 0.0014
69 PRODUCT PREPARATION ISSUE 9 0.0014
70 HEART SOUNDS ABNORMAL 1 0.0013
71 DIAPHRAGMATIC DISORDER 1 0.0013
72 PNEUMONIA MYCOPLASMAL 1 0.0013
73 POOR VENOUS ACCESS 13 0.0013
74 EXPOSURE VIA BREAST MILK 5 0.0013
75 PLACENTAL INSUFFICIENCY 1 0.0012
76 BALANOPOSTHITIS 1 0.0012
77 OESOPHAGEAL RUPTURE 1 0.0012
78 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
79 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
80 SPINAL CORD NEOPLASM 1 0.0011
81 JAW OPERATION 1 0.0011
82 SKIN TEST POSITIVE 1 0.0011
83 CATHETER SITE SWELLING 1 0.0011
84 PRODUCT PREPARATION ERROR 21 0.0010
85 OROPHARYNGEAL SWELLING 1 0.0010
86 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
87 INFUSION SITE DISCOMFORT 1 0.0010
88 DEVICE INEFFECTIVE 1 0.0009
89 PILOERECTION 1 0.0009
90 ALLODYNIA 1 0.0009
91 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
92 INFUSION SITE SWELLING 5 0.0008
93 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
94 WHITE MATTER LESION 1 0.0008
95 MALLORY-WEISS SYNDROME 1 0.0008
96 GESTATIONAL HYPERTENSION 1 0.0008
97 DACRYOSTENOSIS ACQUIRED 1 0.0008
98 RHINOVIRUS INFECTION 3 0.0008
99 PHARYNGEAL ULCERATION 1 0.0008
100 INTESTINAL MASS 1 0.0007
101 DRUG SPECIFIC ANTIBODY 1 0.0007
102 THERAPEUTIC PROCEDURE 1 0.0007
103 TRACHEOSTOMY 1 0.0007
104 FIBULA FRACTURE 2 0.0007
105 PULMONARY FUNCTION TEST DECREASED 3 0.0007
106 HYPERCAPNIA 2 0.0007
107 CENTRAL VENOUS CATHETERISATION 2 0.0007
108 MASTICATION DISORDER 2 0.0007
109 BLOOD CREATININE DECREASED 2 0.0006
110 OPHTHALMOPLEGIA 1 0.0006
111 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
112 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
113 WEIGHT FLUCTUATION 6 0.0006
114 INDURATION 1 0.0006
115 CARDIAC ABLATION 1 0.0006
116 PHARYNGITIS STREPTOCOCCAL 6 0.0006
117 CATHETER SITE INFECTION 2 0.0005
118 ADRENAL DISORDER 1 0.0005
119 OCULAR HYPERTENSION 1 0.0005
120 ALCOHOL INTERACTION 1 0.0005
121 SKIN ODOUR ABNORMAL 2 0.0005
122 UNDERWEIGHT 1 0.0005
123 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
124 SKIN INDURATION 1 0.0005
125 LIVEDO RETICULARIS 1 0.0005
126 MUSCLE FATIGUE 2 0.0005
127 PHARYNGEAL ERYTHEMA 1 0.0005
128 SPUTUM INCREASED 1 0.0005
129 COLONOSCOPY 1 0.0005
130 SPINAL COLUMN INJURY 1 0.0004
131 OROPHARYNGEAL DISCOMFORT 4 0.0004
132 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
133 RESPIRATORY TRACT CONGESTION 7 0.0004
134 METASTATIC MALIGNANT MELANOMA 1 0.0004
135 HAEMANGIOMA 1 0.0004
136 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
137 WEIGHT ABNORMAL 1 0.0004
138 STARING 1 0.0004
139 HAEMATOLOGICAL INFECTION 1 0.0004
140 PHARYNGEAL SWELLING 4 0.0004
141 HYPERVOLAEMIA 2 0.0004
142 INJECTION SITE ABSCESS 1 0.0004
143 PHLEBITIS 2 0.0004
144 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
145 CLUMSINESS 1 0.0004
146 HEART RATE ABNORMAL 2 0.0004
147 ENDOTRACHEAL INTUBATION 1 0.0004
148 PERIORBITAL SWELLING 2 0.0004
149 OXYGEN SATURATION ABNORMAL 1 0.0004
150 MUSCLE STRAIN 3 0.0003
151 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
152 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
153 EAR INFECTION 9 0.0003
154 DUODENITIS 1 0.0003
155 INTERCEPTED PRODUCT PREPARATION ERROR 4 0.0003
156 FOREIGN BODY IN THROAT 1 0.0003
157 INFUSION SITE PRURITUS 1 0.0003
158 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
159 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
160 ILLNESS 32 0.0003
161 POSTURE ABNORMAL 1 0.0003
162 HYPOGAMMAGLOBULINAEMIA 2 0.0003
163 SUSPECTED COVID-19 1 0.0003
164 RESPIRATORY DISORDER 9 0.0003
165 THROAT TIGHTNESS 8 0.0003
166 TACHYPNOEA 4 0.0003
167 RESPIRATION ABNORMAL 2 0.0003
168 CERVICAL VERTEBRAL FRACTURE 1 0.0003
169 BLOOD CREATININE ABNORMAL 1 0.0003
170 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
171 HYPOPNOEA 1 0.0003
172 WEIGHT INCREASED 64 0.0003
173 OXYGEN SATURATION DECREASED 16 0.0003
174 HANGOVER 1 0.0003
175 JOINT DISLOCATION 3 0.0003
176 LUNG TRANSPLANT 1 0.0003
177 CAROTID ARTERY OCCLUSION 1 0.0003
178 FOOT DEFORMITY 3 0.0003
179 RESPIRATORY TRACT INFECTION 7 0.0003
180 SUNBURN 2 0.0003
181 THROAT CLEARING 1 0.0003
182 DERMATITIS CONTACT 3 0.0003
183 INFUSION RELATED REACTION 17 0.0003
184 PROSTATOMEGALY 1 0.0003
185 CEREBRAL ATROPHY 1 0.0003
186 TRIGEMINAL NEURALGIA 1 0.0002
187 EXTRAVASATION 1 0.0002
188 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
189 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
190 POOR PERIPHERAL CIRCULATION 1 0.0002
191 HEPATIC LESION 1 0.0002
192 HORDEOLUM 1 0.0002
193 SKIN SWELLING 2 0.0002
194 MONOPLEGIA 1 0.0002
195 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
196 SINUS CONGESTION 3 0.0002
197 GASTROENTERITIS VIRAL 4 0.0002
198 PALLOR 6 0.0002
199 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
200 LUMBAR VERTEBRAL FRACTURE 1 0.0002
201 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
202 INTERCEPTED MEDICATION ERROR 1 0.0002
203 TIBIA FRACTURE 1 0.0002
204 PRE-ECLAMPSIA 1 0.0002
205 HOSPICE CARE 2 0.0002
206 LIGAMENT SPRAIN 2 0.0002
207 HEPATIC ENZYME ABNORMAL 1 0.0002
208 CORONARY ARTERY STENOSIS 1 0.0002
209 HIP ARTHROPLASTY 3 0.0002
210 PETIT MAL EPILEPSY 1 0.0002
211 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
212 SWOLLEN TONGUE 6 0.0002
213 PARTIAL SEIZURES 1 0.0002
214 INCONTINENCE 2 0.0002
215 INTESTINAL RESECTION 1 0.0002
216 BEHAVIOUR DISORDER 1 0.0002
217 HIP SURGERY 1 0.0002
218 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
219 PRODUCT PRESCRIBING ISSUE 4 0.0002
220 FAECALOMA 1 0.0002
221 ANAPHYLACTIC REACTION 10 0.0002
222 STREPTOCOCCAL INFECTION 1 0.0002
223 NECROSIS 1 0.0002
224 SKIN INFECTION 2 0.0002
225 EXERCISE TOLERANCE DECREASED 1 0.0002
226 SKIN WARM 1 0.0002
227 URINE ODOUR ABNORMAL 1 0.0002
228 PLEURISY 1 0.0002
229 WEIGHT DECREASED 46 0.0002
230 FOETAL GROWTH RESTRICTION 1 0.0002
231 INFUSION SITE PAIN 2 0.0002
232 CARDIAC FLUTTER 1 0.0002
233 SARS-COV-2 TEST POSITIVE 2 0.0002
234 VIRAL INFECTION 5 0.0002
235 BREAST CANCER FEMALE 4 0.0001
236 MUSCULAR WEAKNESS 17 0.0001
237 POSTOPERATIVE WOUND INFECTION 1 0.0001
238 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
239 BODY TEMPERATURE INCREASED 3 0.0001
240 RETCHING 3 0.0001
241 JOINT INJURY 3 0.0001
242 FEAR OF INJECTION 1 0.0001
243 TONGUE DISORDER 1 0.0001
244 FAECES SOFT 1 0.0001
245 BLINDNESS TRANSIENT 1 0.0001
246 BLOOD PRESSURE DECREASED 9 0.0001
247 ARTHROPOD BITE 1 0.0001
248 INFLUENZA 15 0.0001
249 IMMUNODEFICIENCY 2 0.0001
250 NEPHROLITHIASIS 6 0.0001
251 ANKLE FRACTURE 2 0.0001
252 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
253 PELVIC FRACTURE 1 0.0001
254 BRAIN FOG 2 0.0001
255 CHEST DISCOMFORT 13 0.0001
256 PNEUMOTHORAX 2 0.0001
257 MOBILITY DECREASED 9 0.0001
258 NASOPHARYNGITIS 23 0.0001
259 TACHYCARDIA 11 0.0001
260 MUSCLE DISORDER 1 0.0001
261 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
262 ABNORMAL FAECES 1 0.0001
263 HYPERAESTHESIA 1 0.0001
264 MUSCLE INJURY 1 0.0001
265 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
266 POLLAKIURIA 5 0.0001
267 COVID-19 21 0.0001
268 CHILLS 14 0.0001
269 EYE PRURITUS 4 0.0001
270 INFUSION SITE ERYTHEMA 1 0.0001
271 FLUSHING 12 0.0001
272 VITAMIN D DECREASED 1 0.0001
273 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
274 MYOPATHY 1 0.0001
275 EXPOSURE VIA SKIN CONTACT 3 0.0001
276 MENTAL DISORDER 5 0.0001
277 SPEECH DISORDER 6 0.0001
278 URINE OUTPUT DECREASED 1 0.0001
279 OFF LABEL USE 100 0.0001
280 HEART RATE DECREASED 4 0.0001
281 COLD SWEAT 2 0.0001
282 LUNG INFILTRATION 1 0.0001
283 PYREXIA 39 0.0001
284 GASTROINTESTINAL INFECTION 1 0.0001
285 JAUNDICE 3 0.0001
286 EXOSTOSIS 1 0.0001
287 PNEUMONIA BACTERIAL 1 0.0001
288 UROSEPSIS 1 0.0001
289 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
290 OROPHARYNGEAL PAIN 10 0.0001
291 CONJUNCTIVITIS 2 0.0001
292 FLANK PAIN 1 0.0001
293 MYALGIA 18 0.0001
294 CONDITION AGGRAVATED 32 0.0001
295 EYE INFLAMMATION 1 0.0001
296 SLEEP APNOEA SYNDROME 2 0.0001
297 PRODUCTIVE COUGH 5 0.0001
298 PANCREATIC CARCINOMA 3 0.0001
299 ATELECTASIS 1 0.0001
300 DYSSTASIA 3 0.0001
301 CHOKING 2 0.0001
302 VITREOUS FLOATERS 1 0.0001
303 URTICARIA 17 0.0001
304 HEART RATE INCREASED 10 0.0001
305 SALIVARY HYPERSECRETION 1 0.0001
306 BRAIN INJURY 1 0.0001
307 THERAPEUTIC RESPONSE DECREASED 6 0.0001
308 EYELID PTOSIS 1 0.0001
309 INITIAL INSOMNIA 1 0.0001
310 TEMPERATURE INTOLERANCE 1 0.0001
311 EYE DISCHARGE 1 0.0001
312 TRANSFUSION 1 0.0001
313 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
314 SCRATCH 1 0.0001
315 DISEASE PROGRESSION 11 0.0001
316 BACK INJURY 1 0.0001
317 CHEST PAIN 17 0.0001
318 TOOTH FRACTURE 1 0.0001
319 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
320 LIP SWELLING 3 0.0001
321 TOOTH DISORDER 2 0.0001
322 SCAB 1 0.0001
323 ERYTHEMA 18 0.0001
324 MICTURITION URGENCY 1 0.0001
325 PERICARDIAL EFFUSION 2 0.0001
326 COUGH 24 0.0001
327 DYSPHAGIA 8 0.0001
328 FALL 28 0.0001
329 WRIST FRACTURE 1 0.0001
330 INCORRECT DOSE ADMINISTERED 19 0.0001
331 PRESYNCOPE 2 0.0001
332 SMALL INTESTINAL OBSTRUCTION 1 0.0001
333 INJECTION SITE EXTRAVASATION 1 0.0001
334 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
335 PNEUMONIA 26 0.0001
336 HYPERTENSION 17 0.0001
337 MYDRIASIS 1 0.0001
338 TOOTH INFECTION 1 0.0001
339 MALIGNANT MELANOMA 1 0.0001
340 RESPIRATORY DISTRESS 2 0.0001
341 ROAD TRAFFIC ACCIDENT 3 0.0001
342 APHONIA 1 0.0001
343 PERIPHERAL SWELLING 11 0.0001
344 SKIN REACTION 1 0.0001
345 LYMPHOPENIA 1 0.0001
346 PAIN IN JAW 2 0.0001
347 INTENTIONAL DOSE OMISSION 2 0.0001
348 PARAESTHESIA ORAL 1 0.0001
349 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
350 HYPERTHYROIDISM 1 0.0001
351 HYPOKINESIA 1 0.0001
352 PRODUCT STORAGE ERROR 6 0.0001
353 NASAL CONGESTION 4 0.0001
354 COLON CANCER 1 0.0001
355 THROAT IRRITATION 3 0.0001
356 HYPOAESTHESIA ORAL 1 0.0001
357 LACRIMATION INCREASED 2 0.0001
358 BLOOD PRESSURE INCREASED 10 0.0001
359 FEELING HOT 4 0.0001
360 DEVICE RELATED INFECTION 1 0.0001
361 TENDONITIS 1 0.0001
362 BACK PAIN 15 0.0001
363 PAIN IN EXTREMITY 19 0.0001
364 GAIT DISTURBANCE 12 0.0001
365 DYSPNOEA 35 0.0001
366 MUSCLE TIGHTNESS 1 0.0001
367 STAPHYLOCOCCAL INFECTION 2 0.0001
368 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
369 GAIT INABILITY 2 0.0001
370 CELLULITIS 3 0.0001
371 CANDIDA INFECTION 1 0.0001
372 HEMIPARESIS 1 0.0001
373 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
374 MUSCULOSKELETAL DISCOMFORT 1 0.0001
375 PRURITUS 22 0.0001
376 HYPOXIA 2 0.0001
377 RESPIRATORY FAILURE 4 0.0001
378 MALAISE 24 0.0001
379 DYSURIA 2 0.0001
380 BLOOD GLUCOSE ABNORMAL 1 0.0001
381 EYE SWELLING 2 0.0001
382 NECK PAIN 3 0.0001
383 THINKING ABNORMAL 1 0.0001
384 MIDDLE INSOMNIA 1 0.0001
385 SWELLING 5 0.0001
386 EYE PAIN 3 0.0001
387 DYSARTHRIA 2 0.0001
388 BLOOD SODIUM DECREASED 1 0.0001
389 BLOOD URINE PRESENT 1 0.0001
390 PROTEINURIA 1 0.0001
391 MUSCULOSKELETAL DISORDER 1 0.0001
392 HOSPITALISATION 8 0.0001
393 LOWER LIMB FRACTURE 1 0.0001
394 EAR PAIN 1 0.0001
395 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
396 PALPITATIONS 6 0.0001
397 KIDNEY INFECTION 1 0.0001
398 WHEEZING 3 0.0001
399 SINUS DISORDER 1 0.0001
400 ABNORMAL BEHAVIOUR 2 0.0001
401 BLOOD PRESSURE ABNORMAL 1 0.0001
402 NO ADVERSE EVENT 9 0.0000
403 FEEDING DISORDER 1 0.0000
404 SINUSITIS 5 0.0000
405 PERITONITIS 1 0.0000
406 RASH 21 0.0000
407 ASTHENIA 18 0.0000
408 EATING DISORDER 1 0.0000
409 LOSS OF CONSCIOUSNESS 6 0.0000
410 HYPOACUSIS 2 0.0000
411 SKIN CANCER 1 0.0000
412 RHINORRHOEA 3 0.0000
413 FATIGUE 36 0.0000
414 SWELLING FACE 3 0.0000
415 PRODUCT DISPENSING ERROR 1 0.0000
416 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
417 ORAL PAIN 1 0.0000
418 HEADACHE 28 0.0000
419 RASH PAPULAR 1 0.0000
420 SNEEZING 1 0.0000
421 HEART RATE IRREGULAR 1 0.0000
422 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
423 CARDIAC DISORDER 4 0.0000
424 ARRHYTHMIA 2 0.0000
425 OCULAR HYPERAEMIA 2 0.0000
426 PRODUCT PRESCRIBING ERROR 1 0.0000
427 BLOOD PRESSURE FLUCTUATION 1 0.0000
428 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
429 HEPATIC CANCER 1 0.0000
430 CEREBRAL INFARCTION 1 0.0000
431 LUNG DISORDER 2 0.0000
432 PNEUMONIA ASPIRATION 1 0.0000
433 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
434 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
435 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
436 ANAPHYLACTIC SHOCK 1 0.0000
437 SKIN ULCER 1 0.0000
438 HYPERSENSITIVITY 7 0.0000
439 BRADYCARDIA 2 0.0000
440 BLOOD BILIRUBIN INCREASED 1 0.0000
441 FREQUENT BOWEL MOVEMENTS 1 0.0000
442 LIMB INJURY 1 0.0000
443 MOOD ALTERED 1 0.0000
444 TREATMENT NONCOMPLIANCE 2 0.0000
445 INFLUENZA LIKE ILLNESS 3 0.0000
446 CARDIAC ARREST 3 0.0000
447 RESPIRATORY ARREST 1 0.0000
448 DIVERTICULITIS 1 0.0000
449 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
450 FLATULENCE 2 0.0000
451 URINARY TRACT INFECTION 6 0.0000
452 ANXIETY 10 0.0000
453 ANGINA PECTORIS 1 0.0000
454 HYPERSOMNIA 1 0.0000
455 HERPES ZOSTER 2 0.0000
456 SOMNOLENCE 7 0.0000
457 LETHARGY 2 0.0000
458 INFECTION 5 0.0000
459 BONE PAIN 2 0.0000
460 SURGERY 2 0.0000
461 PREMATURE BABY 1 0.0000
462 APHASIA 1 0.0000
463 STOMATITIS 2 0.0000
464 VERTIGO 2 0.0000
465 DISCOMFORT 2 0.0000
466 EPILEPSY 1 0.0000
467 EMOTIONAL DISORDER 1 0.0000
468 LIMB DISCOMFORT 1 0.0000
469 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
470 VOMITING 15 0.0000
471 HEAD INJURY 1 0.0000
472 CHOLELITHIASIS 1 0.0000
473 EYE DISORDER 1 0.0000
474 ABDOMINAL PAIN 7 0.0000
475 SKIN DISORDER 1 0.0000
476 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
477 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
478 VISION BLURRED 4 0.0000
479 ARTHRALGIA 12 0.0000
480 RASH MACULAR 1 0.0000
481 DIZZINESS 14 0.0000
482 NAUSEA 22 0.0000
483 PAIN 17 0.0000
484 CRYING 1 0.0000
485 CONSTIPATION 6 0.0000
486 C-REACTIVE PROTEIN INCREASED 1 0.0000
487 RESTLESSNESS 1 0.0000
488 PRODUCT DOSE OMISSION ISSUE 8 0.0000
489 BRONCHITIS 2 0.0000
490 SEPSIS 3 0.0000
491 DYSPNOEA EXERTIONAL 1 0.0000
492 COLITIS 1 0.0000
493 DIABETES MELLITUS 2 0.0000
494 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
495 SEIZURE 3 0.0000
496 ARTHRITIS 2 0.0000
497 DISORIENTATION 1 0.0000
498 FEELING ABNORMAL 6 0.0000
499 CARDIAC FAILURE 2 0.0000
500 PROSTATE CANCER 2 0.0000
501 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
502 OSTEOPOROSIS 1 0.0000
503 ABDOMINAL PAIN UPPER 5 0.0000
504 CARDIO-RESPIRATORY ARREST 1 0.0000
505 ABDOMINAL DISCOMFORT 4 0.0000
506 RECTAL HAEMORRHAGE 1 0.0000
507 BALANCE DISORDER 2 0.0000
508 VAGINAL HAEMORRHAGE 1 0.0000
509 DEVICE DISLOCATION 1 0.0000
510 MUSCULOSKELETAL STIFFNESS 2 0.0000
511 LIVER DISORDER 1 0.0000
512 DEHYDRATION 3 0.0000
513 DRY SKIN 3 0.0000
514 COLITIS ULCERATIVE 1 0.0000
515 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
516 SKIN IRRITATION 1 0.0000
517 MUSCLE SPASMS 4 0.0000
518 SKIN DISCOLOURATION 1 0.0000
519 DECREASED APPETITE 5 0.0000
520 RENAL DISORDER 1 0.0000
521 BLOOD GLUCOSE INCREASED 4 0.0000
522 PULMONARY EMBOLISM 2 0.0000
523 NEUROPATHY PERIPHERAL 2 0.0000
524 COMA 1 0.0000
525 RASH ERYTHEMATOUS 1 0.0000
526 DRUG INTOLERANCE 2 0.0000
527 HYPOGLYCAEMIA 1 0.0000
528 DYSPEPSIA 2 0.0000
529 DRY EYE 1 0.0000
530 HAEMOGLOBIN DECREASED 2 0.0000
531 PANCREATITIS 1 0.0000
532 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
533 OEDEMA 1 0.0000
534 HAEMATOCHEZIA 1 0.0000
535 TREMOR 3 0.0000
536 ASTHMA 2 0.0000
537 MYOCARDIAL INFARCTION 3 0.0000
538 DYSPHONIA 1 0.0000
539 DIARRHOEA 11 0.0000
540 PLEURAL EFFUSION 1 0.0000
541 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
542 EXPOSURE DURING PREGNANCY 1 0.0000
543 BLOOD CREATININE INCREASED 1 0.0000
544 RENAL FAILURE 2 0.0000
545 BURNING SENSATION 1 0.0000
546 INJURY 1 0.0000
547 HOT FLUSH 1 0.0000
548 UNEVALUABLE EVENT 1 0.0000
549 DEPRESSION 3 0.0000
550 INJECTION SITE SWELLING 1 0.0000
551 PARAESTHESIA 2 0.0000
552 CARDIAC FAILURE CONGESTIVE 1 0.0000
553 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
554 TREATMENT FAILURE 1 0.0000
555 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
556 INSOMNIA 3 0.0000
557 GASTROINTESTINAL DISORDER 1 0.0000
558 BREAST CANCER 1 0.0000
559 CONTUSION 1 0.0000
560 ATRIAL FIBRILLATION 1 0.0000
561 ALOPECIA 2 0.0000
562 SYNCOPE 1 0.0000
563 ABDOMINAL DISTENSION 1 0.0000
564 PLATELET COUNT DECREASED 1 0.0000
565 THROMBOCYTOPENIA 1 0.0000
566 OEDEMA PERIPHERAL 1 0.0000
567 HYPERHIDROSIS 1 0.0000
568 DRUG INEFFECTIVE 10 0.0000
569 PRODUCT QUALITY ISSUE 1 0.0000
570 MEMORY IMPAIRMENT 1 0.0000
571 HYPOAESTHESIA 1 0.0000
572 CONFUSIONAL STATE 1 0.0000
573 CEREBROVASCULAR ACCIDENT 1 0.0000
574 ANAEMIA 1 0.0000
575 HYPOTENSION 1 0.0000
576 DEATH 2 0.0000